Therefore, fully understanding the effects of drugs on hERG channels and discovering the characteristics of drug-inhibiting hERG channels is of great significance for reducing the risk of drug-induced cardiac arrhythmias associated with hERG deficiency or channel blocking, optimizing drug design to minimize adverse effects, and guiding clinical rational drug use (32, 33). Here, KCNH2 is linked to chronic obstructive pulmonary disease.